LTVSPWY Pep-LNP
Cat. No.: TDLD-0126-LD113
LTVSPWY Pep-LNP
LTVSPWY Pep-LNP is an advanced peptide-functionalized lipid nanoparticle (LNP) engineered for targeted delivery of therapeutic cargoes. The LTVSPWY peptide enables specific receptor binding, enhancing delivery efficiency. Applications include developing targeted therapeutics and studying receptor-mediated delivery mechanisms. Please note that this product is intended for research purposes only.
Inquiry
SPECIFIC INQUIRY
Clear All
For Research Use Only. Not for Diagnostic or Treatment Applications.
| Payload Type | mRNA |
| Payload | Empty; EGFP mRNA; Firefly Luciferase mRNA; mCherry mRNA; GFP mRNA; OVA mRNA; EPO mRNA; Renilla Luciferase mRNA; Gaussia Luciferase mRNA; Beta-galactosidase mRNA; Cre mRNA; mOrange mRNA; tdTomato mRNA; EYFP mRNA; Others |
| Capping | Cap 1 |
| Modification | Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other |
| Module Type | Peptide |
| Targeting Module | LTVSPWY Peptide |
| Target | HER2 protein kinase |
| Lipid Formulation | DLin-MC3-DMA; LP-01; ALC-0315; SM102; Other |
| Dye | Unlabeled; DiR; DiD; DiO; DiI; Other |
| Application | Control; Targeted Delivery; Gene Therapy |
| Format | Liquid |
| Concentration | 0.1 mg/mL; 0.2 mg/mL; Other (Please Specify) |
| Size | 65-120 nm |
| PDI | < 0.2 |
| Zeta | ± 20.0 mV |
| Encapsulate Efficiency | >90% |
| Shipping | Dry Ice |
| Storage | Store at -80°C |
Related Products
Asp8 Pep-LNP (TDLD-0825-LD87)
PSMA Pep-LNP (TDLD-0126-LD155)
Fluc CircRNA-LNP (TDLD-0825-LD61)
EGFP mRNA-LNP (TDLD-0825-LD10)
BCMA CAR mRNA-LNP (TDLD-0825-LD49)
IMTP Pep-LNP (TDLD-0126-LD106)
tdTomato mRNA-LNP (TDLD-0825-LD26)
Cy3-labeled Fluc mRNA-LNP (TDLD-0825-LD25)
Online Inquiry
